Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria will be individuals requiring dialysis for treatment of ESRD who have had poor response to immunosuppressive strategies.~* Non-Diabetic~* Adults age 18-80~Exclusion Criteria:~* receiving hemodialysis for \> 5 years~* diabetic, less than 18 years of age~* are pregnant~* have a history of cancer in the last 5 years~* have an active infection~* have recently had a myocardial infarction (within 6 weeks)~* have malignant arrhythmias, unstable angina, uncontrolled hypertension (SBP\> 180 and/or DBP \> 105)~* recent hospitalization (\< 30 days),~* ocular disease,~* accelerated osteoporosis,~* gastrointestinal diseases (ulcerative colitis, diverticulitis, myasthenia gravis)~* any disorder that may be exacerbated by short periods of activity.~* cognitive dysfunction~* neurological deficits leading to limited ambulation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 80 Units of Acthar (Type: ACTIVE_COMPARATOR): Subjects assigned by random assignment to receive 80 Units of Acthar Gel 2x weekly for 6 months
- 40 Units of Acthar (Type: ACTIVE_COMPARATOR): Subjects assigned by random assignment to receive 40 Units of Acthar Gel 2x weekly for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).